ABSTRACT:
A simple, sensitive, accurate, rapid and economical Spectrophotometric method was developed for estimation and validation of Finerenone in pure drug and tablet dosage form. The absorbance was measured at 239.8nm using Ethanol as solvent system. It obeyed Beer’s law at the concentration range of 2-14µg/ml with coefficient of correlation (r2) of 0.997. Limit of detection (LOD) was found to be 1.220µg/ml and Limit of quantitation (LOQ) was found to be 5.220µg/ml. The proposed analytical method was validated according to ICH guidelines, yielded good results concerning range, linearity, precision, accuracy, robustness and ruggedness.
Cite this article:
HusnainFathima, Mahboob Pasha, Mohamed Khaleel. Estimation and Validation of Finerenone in Dosage Form and in Bulk Drug by Spectrophotometric Method. Asian Journal of Research in Chemistry 2023; 16(3):211-5. doi: 10.52711/0974-4150.2023.00033
Cite(Electronic):
HusnainFathima, Mahboob Pasha, Mohamed Khaleel. Estimation and Validation of Finerenone in Dosage Form and in Bulk Drug by Spectrophotometric Method. Asian Journal of Research in Chemistry 2023; 16(3):211-5. doi: 10.52711/0974-4150.2023.00033 Available on: https://ajrconline.org/AbstractView.aspx?PID=2023-16-3-3
REFERENCES:
1. "Updates to the Prescribing Medicines in Pregnancy database". Therapeutic Goods Administration (TGA). 12 May 2022. Retrieved 13 May 2022.
2. "Kerendia APMDS". Therapeutic Goods Administration (TGA). 9 December 2021. Retrieved 12 June 2022.
3. "AusPAR: Finerenone". Therapeutic Goods Administration (TGA). 31 May 2022. Retrieved 12 June 2022.
4. Kerendia- finerenone tablet, film coated". Daily Med. Retrieved 20 August 2021
5. "FDA Approves Drug for Chronic Kidney Disease". U.S. Food and Drug Administration (FDA). 9 July 2021. Retrieved 9 July 2021. Public Domain This article incorporates text from this source, which is in the public domain.
6. Kerendia EPAR". European Medicines Agency (EMA). 14 December 2021. Retrieved 11 March 2022. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
7. "Bayer's Kerendia (finerenone) Receives U.S. FDA Approval for Treatment of Patients with Chronic Kidney Disease Associated with Type 2 Diabetes" (Press release). Bayer. 9 July 2021. Retrieved 9 July 2021 – via Business Wire.
8. https://go.drugbank.com/drugs/DB16165
9. https://www.selleckchem.com/products/finerenone.html
10. Cunanan P R J, Navarro R C, Robles J A P, Sanchez B M D, Tuazon H J G, Soriano P G, Depression and quality of life among Chronic Kidney Disease Patients on Hemodialysis at selected Stand-alone Renal Facilities in Manila: a cross-sectional study. Asian Journal of Nursing Education and Research. 2019; 9(2): 2349-2996
11. H Fathima, Havannavar T N, Jahan A, Estimation and Validation of Remogliflozin Etabonate in Dosage form and in Bulk Drug by Spectrophotometeric Method. Asian Journal of Research in Chemistry. 2022;15(2):166-0
12. Vichare V, Suryawanshi P, Bhosale J, Dhole S. Simultaneous estimation of Metformin HCl and Pioglitazone HCl by Second Order Derivative UV- Visible Spectrophotometric Method in Tablet Formulation, Asian Journal of Pharmaceutical Analysis. 2014;4(3):121-124
13. Rao VB, Vijetha P, Vidyadhara S, Kavita K. A Novel RP-HPLC Method Development and Validation for the Determination of Pioglitazone and Glimepride in Bulk and Pharmaceutical Formulations, Asian Journal of Pharmaceutical Analysis. 2017; 7(3): 145-150
14. Pawar J, Sonawane S, Chhajed S, Kshirsagar S. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Metformin HCl and Gliclazide, Asian Journal of Pharmaceutical Analysis. 2016; 6(3):151-154
15. Rao VB, Vijetha P, Vidyadhara S, Kavita K. A Novel RP-HPLC Method Development and Validation for the Determination of Pioglitazone and Glimepride in Bulk and Pharmaceutical Formulations, Asian Journal of Pharmaceutical Analysis. 2017;7(3):145-150
16. Gadge SS, Nakod DA, Wasnik PV, Gatkine MT, Zile SS, Mohije HN, Salode LV. Development and Validation of Q-absorbance Ratio method for Simultaneous Estimation of Teniligliptin hydrobromide and Metformin HCl in Multicomponent Dosage form. Asian Journal of Pharmaceutical Analysis. 2019;9(4):215-218
17. Venkatesh S, Jyothi S, Chiluka R, Padmavati Y. Development of UV-Spectrophotometric Method for the Simultaneous Estimation of Nateglinide and Piperine in combined tablet dosage form. Asian Journal of Pharmaceutical Analysis. 2020;10(3):134-140
18. Farkade K, Tawar M. Analytical Method Validation and Quantitative Analysis for Active Pharmaceutical Ingredient and Marketed Formulation of Teniligliptin Hydrobromide by UV Spectroscopy. Asian Journal of Pharmaceutical Analysis. 2021;11(3):195-8
19. More SS, Sonawane SS, Chhajed SS, Kshirsagar JS. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Saxagliptin and Dapagliflozin in Tablets. Asian Journal of Pharmacy and Technology. 2018;8(3):145-148
20. Harikrishnan N, MuraliKrishna U, Shaik B, Bhavsar V, V Manjusha, Kumar RV. Development and Validation of UV-Spectrophotometric Method of Glibenclamide (Glyburide) in Bulk and Pharmaceutical Formulations. Asian Journal of Research in Chemistry. 2010;3(2):316-318